These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30377134)

  • 1. [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].
    Cao K; Sun L; Zhang Y; Wang T; Li H; Zuo S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1234-1238. PubMed ID: 30377134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mir-637 inhibits the proliferation of cholangiocarcinoma cell QBC939 through interfering CTSB expression.
    Li JX; Ding XM; Han S; Wang K; Jiao CY; Li XC
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1265-1276. PubMed ID: 29565483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression.
    Cao K; Li B; Zhang YW; Song H; Chen YG; Gong YJ; Li HY; Zuo S
    Aging (Albany NY); 2021 Feb; 13(4):6055-6065. PubMed ID: 33601338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin/miR-29b combination therapy increases the pro-apoptotic effect of dihydroartemisinin on cholangiocarcinoma cell lines by regulating Mcl-1 expression.
    Hu H; Wang Z; Tan C; Liu X; Zhang H; Li K
    Adv Clin Exp Med; 2020 Aug; 29(8):911-919. PubMed ID: 32790250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.
    Wu C; Zhang J; Cao X; Yang Q; Xia D
    Med Sci Monit; 2016 Jul; 22():2685-90. PubMed ID: 27472451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z; Chen ML; He QL; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
    Okamoto K; Miyoshi K; Murawaki Y
    PLoS One; 2013; 8(10):e77623. PubMed ID: 24147037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
    Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
    BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
    Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
    J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells.
    Cheng W; Liu Y; Zuo Z; Yin X; Jiang B; Chen D; Peng C; Yang J
    Int J Clin Exp Pathol; 2015; 8(12):15511-26. PubMed ID: 26884821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclooxygenase-2 antisense vector on proliferation of human cholangiocarcinoma cells.
    Wu GS; Zou SQ; Wu XY; Qiu FZ
    Chin Med Sci J; 2004 Jun; 19(2):89-92. PubMed ID: 15250241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1.
    Lv P; Luo YF; Zhou WY; Liu B; Zhou Z; Shi YZ; Huang R; Peng C; He ZL; Wang J; Zhang HH; Nie SD
    Kaohsiung J Med Sci; 2020 Jun; 36(6):429-440. PubMed ID: 32125086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.
    Lu WX
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7356-7368. PubMed ID: 31539122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis.
    Lu M; Qin X; Zhou Y; Li G; Liu Z; Yue H; Geng X
    Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
    Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
    Int J Oncol; 2013 Feb; 42(2):690-8. PubMed ID: 23254774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-146b-5p suppresses cholangiocarcinoma cells by targeting TRAF6 and modulating p53 translocation.
    Ren Y; Wang X; Ji T; Cai X
    Acta Histochem; 2021 Oct; 123(7):151793. PubMed ID: 34610483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
    Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
    FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.